Welcome to our dedicated page for Skyward Specialty Insurance Group SEC filings (Ticker: SKWD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Skyward Specialty Insurance Group, Inc. (Nasdaq: SKWD) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a specialty commercial property and casualty insurer. As a Nasdaq Global Select Market registrant, Skyward Specialty files current and periodic reports with the U.S. Securities and Exchange Commission that describe its financial condition, capital structure, governance, and material events.
Investors can review Form 8-K filings for information on material definitive agreements, credit facilities, acquisitions, and governance developments. For example, recent 8-K filings describe a new unsecured revolving credit agreement with specified covenants and an accordion feature, the termination of a prior credit agreement, and share purchase agreements related to the acquisition of Apollo Group Holdings Limited. Other 8-Ks report quarterly results and board changes, such as the election of a new independent director and planned Audit Committee leadership transitions.
Annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via this page when filed) provide more detailed information on Skyward Specialty’s underwriting divisions, specialty P&C operations, risk factors, and financial statements. These filings also discuss topics such as reinsurance arrangements, reserves, investment portfolios, and non-GAAP financial measures used by management.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping users quickly identify items such as changes in credit arrangements, acquisition terms, or underwriting performance metrics. The filings page is also a resource for tracking any future Forms 3, 4, or 5 related to insider transactions, as well as proxy statements that address board composition and executive-related matters, when such documents are filed with the SEC.
Skyward Specialty Insurance Group reported a very strong fourth quarter and full-year 2025. Q4 2025 net income rose to $43.2 million, or $1.03 per diluted share, from $14.4 million, or $0.35, in Q4 2024. Full-year 2025 net income reached $170.0 million, or $4.07 per diluted share, up from $118.8 million, or $2.87, in 2024.
Gross written premiums were $439.5 million in Q4 2025, a 13.2% increase, and $2.17 billion for 2025, up 24.3%, driven by accident & health, specialty programs, surety, and agriculture and credit (re)insurance. The Q4 combined ratio improved to 88.5%, with an ex-cat combined ratio of 87.7%, and the full-year combined ratio improved to 89.3%.
Adjusted operating income was $48.9 million in Q4 2025, or $1.17 per diluted share, versus $33.2 million, or $0.80, a year earlier. For 2025, adjusted operating income was $167.4 million, or $4.00 per diluted share. Return on equity for the year was 18.9%, and book value per share increased to $24.92 at December 31, 2025, up 26% from December 31, 2024.
Reinhart Partners, LLC has disclosed a significant ownership stake in Skyward Specialty Insurance Group, Inc. As of the event date of 12/31/2025, Reinhart reports beneficial ownership of 2,416,753 shares of Skyward’s common stock, representing 5.97% of the outstanding class.
The firm has sole voting power over 2,217,570 shares and sole dispositive power over 2,416,753 shares, with no shared voting or dispositive authority. Reinhart states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Skyward.
Skyward Specialty Insurance Group, Inc. chief people officer Thomas N. Schmitt reported a sale of 2,616 shares of common stock on February 9, 2026 at a weighted average price of $43.4916 per share. After this sale, he beneficially owned 14,747 shares directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that Schmitt adopted on September 11, 2025. The shares were sold in multiple trades at prices ranging from $43.15 to $43.78, with the weighted average price reported.
A shareholder of Skyward Specialty Insurance Inc. has filed a notice of proposed sale under Rule 144 for 2,616 shares of common stock. The planned sale, through Merrill Lynch, has an aggregate market value of $113,695.75 and is targeted around February 9, 2026 on the NYSE.
The filing notes that 40,487,365 shares of common stock were outstanding, providing context for the size of the planned transaction. The shares to be sold were acquired as stock bonus compensatory payments on January 1, 2025. In the past three months, a prior sale of 88 shares generated $4,169.73 in gross proceeds.
Skyward Specialty Insurance Group, Inc. director reports no holdings. A Form 3 was filed for director Peirce Christopher Locke reporting initial beneficial ownership status as of 02/01/2026. The filing states that no securities of Skyward Specialty Insurance Group, Inc. are beneficially owned, and both non-derivative and derivative tables show no positions.
Skyward Specialty Insurance Group CPO Thomas N. Schmitt reported stock activity tied to previously granted restricted stock units. On January 12, 2026, 5,000 shares of common stock were issued upon settlement of a 2023 IPO 4-year RSU grant and another 5,000 shares were issued from a 2023 IPO 3-year RSU grant, both at an exercise price of $0. To satisfy tax withholding on these vestings, the issuer withheld 2,149 shares and 1,968 shares at a price of $46.10 per share, which the footnotes state was mandated by the company and not a discretionary sale by Schmitt. Following these transactions, Schmitt directly beneficially owned 17,363 shares of Skyward common stock, and 5,000 RSUs from the 4-year grant remain outstanding.
Skyward Specialty Insurance Group EVP & Chief Claims Officer Sean W. Duffy reported restricted stock unit vesting and related tax withholding transactions in company stock. On January 12, 2026, 5,000 shares of common stock were issued upon settlement of a 2023 IPO RSU grant and another 5,000 shares were issued from a separate 2023 IPO RSU grant, both at an exercise price of $0. To cover tax obligations tied to these RSU vestings, the issuer withheld 2,276 shares and 2,095 shares at a price of $46.10 per share, which the filing notes as mandated by the company rather than discretionary sales by Duffy. Following these transactions, Duffy directly beneficially owned 16,036 shares of Skyward Specialty Insurance Group common stock.
Skyward Specialty Insurance Group Head of Actuarial Sandip A. Kapadia reported equity award activity tied to restricted stock units. On January 12, 2026, 5,000 shares of common stock were issued upon settlement of a 2023 IPO 4-year RSU grant and another 5,000 shares were issued from a 2023 IPO 3-year RSU grant, with each RSU converting into one share of common stock at an exercise price of $0.
On the same date, the issuer withheld 1,985 shares and 1,808 shares of common stock, respectively, to satisfy tax withholding obligations, using a share value of $46.10 based on the closing price on the vesting date. After these transactions, Kapadia directly beneficially owned 15,545 shares of Skyward Specialty Insurance Group common stock. The filing states that the tax-related share withholding was mandated by the company and was not a discretionary sale.
Skyward Specialty Insurance Group, Inc. officer John A. Burkhart III, President, US P&C, reported equity transactions on January 12, 2026 related to restricted stock unit (RSU) awards. He settled a total of 13,330 RSUs into common stock, with 6,665 shares from a 4-year 2023 IPO RSU grant and 6,665 shares from a 3-year 2023 IPO RSU grant, each RSU converting into one share at an exercise price of $0. To cover tax withholding obligations on these vestings, the issuer withheld 2,798 shares and 2,623 shares of common stock at a price of $46.1 per share, as mandated under the company’s long-term incentive plan. After these transactions, Burkhart directly beneficially owned 32,271 shares of common stock.
Skyward Specialty Insurance Group Chairman and CEO Andrew S. Robinson reported the vesting and settlement of restricted stock units into common stock. On January 12, 2026, 100,000 RSUs from two 2023 IPO grants converted into 100,000 shares of common stock at an exercise price of $0. In connection with this vesting, a total of 39,532 shares were withheld by the company to cover tax obligations, using a share value of $46.10 on the vesting date. After these transactions, Robinson directly beneficially owned 134,915 shares of common stock. The 4-year IPO RSU grant shows 50,000 derivative RSUs remaining outstanding, while the 3-year IPO RSU grant is now fully settled.